Amelogenin-based sex identification as a strategy to control the identity of DNA samples in genetic association studies

Pharmacogenomics

Volumn 11, Issue 3, 2010, Pages 449-457

  Tzvetkov, Mladen Vassilev ^a   Meineke, Ingolf ^b   Sehrt, Daniel ^b   Vormfelde, Stefan Viktor ^b   Brockmller, Jürgen ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NONE

Author keywords

Amelogenin; AMELX; AMELY; Association studies; PCR RFLP; Quality control; Sample mix up; Sample swap; Sex typing; SNaPshotTM; TaqMan

Indexed keywords

AMELOGENIN;

AMELX GENE; AMELY GENE; ANALYTIC METHOD; DNA DETERMINATION; GENE; GENE DELETION; GENE INSERTION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENOME ANALYSIS; GENOTYPE; HUMAN; PROBABILITY; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SEX DETERMINATION; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDITY; X CHROMOSOME; Y CHROMOSOME;

AMELOGENIN; BASE SEQUENCE; DNA; DNA PRIMERS; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; QUALITY CONTROL; SEX DETERMINATION (ANALYSIS);

EID: 77949591938     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.10.14     Document Type: Review

References (33)

1. The Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145), 661-678 (2007).
2. Barrett JC, Hansoul S, Nicolae DL et al.: Genome-wide association defnes more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40(8), 955-962 (2008).
3. Ahn K, Gordon D, Finch SJ: Increase of rejection rate in case-control studies with the differential genotyping error rates. Stat. Appl. Genet. Mol. Biol. 8(1), 25 (2009).
4. Fu W, Wang Y, Wang Y, Li R, Lin R, Jin L: Missing call bias in high-throughput genotyping. BMC Genomics 10, 106 (2009).
5. Heid IM, Lamina C, Kuchenhoff H et al.: Estimating the single nucleotide polymorphism genotype misclassifcation from routine double measurements in a large epidemiologic sample. Am. J. Epidemiol. 168(8), 878-889 (2008).
6. Kang SJ, Gordon D, Finch SJ: What SNP genotyping errors are most costly for genetic association studies? Genet. Epidemiol. 26(2), 132-141 (2004).
7. Kottgen A, Glazer NL, Dehghan A et al.: Multiple loci associated with indices of renal function and chronic kidney disease. Nat. Genet. (2009) (Epub ahead of print
8. Levy D, Ehret GB, Rice K et al.: Genome-wide association study of blood pressure and hypertension. Nat. Genet. 41, 677-687 (2009).
9. Stolk L, Zhai G, van Meurs JB et al.: Loci at chromosomes 13, 19 and 20 infuence age at natural menopause. Nat. Genet. 41, 645-647 (2009).
10. Sullivan KM, Mannucci A, Kimpton CP, Gill P: A rapid and quantitative DNA sex test: fuorescence-based pcr analysis of X-Y homologous gene amelogenin. Biotechniques 15(4), 636-638, 640-1631 (1993).
11. von Wurmb-Schwark N, Bosinski H, Ritz-Timme S: What do the X and Y chromosomes tell us about sex and gender in forensic case analysis? J. Forensic Leg. Med. 14(1), 27-30 (2007).
12. Vormfelde SV, Hoell I, Tzvetkov M et al.: Anxiety-and novelty seeking-related personality traits and serotonin transporter gene polymorphisms. J. Psychiatr. Res. 40(6), 568-576 (2006).
13. Lattanzi W, Di Giacomo MC, Lenato GM et al.: A large interstitial deletion encompassing the amelogenin gene on the short arm of the Y chromosome. Hum. Genet. 116(5), 395-401 (2005).
14. Santos FR, Pandya A, Tyler-Smith C: Reliability of DNA-based sex tests. Nat. Genet. 18(2), 103 (1998).
15. Chang YM, Burgoyne LA, Both K: Higher failures of amelogenin sex test in an Indian population group. J. Forensic Sci. 48(6), 1309-1313 (2003).
16. Thangaraj K, Reddy AG, Singh L: Is the amelogenin gene reliable for gender identifcation in forensic casework and prenatal diagnosis? Int. J. Legal Med. 116(2), 121-123 (2002).
17. Cai LQ, Zhu YS, Katz MD et al.: 5 a-reductase-2 gene mutations in the Dominican Republic. J. Clin. Endocrinol. Metab. 81(5), 1730-1735 (1996).
18. Chester MA, Olsson ML: The ABO blood group gene: a locus of considerable genetic diversity. Transfus. Med. Rev. 15(3), 177-200 (2001).
19. Ferri G, Bini C, Ceccardi S, Pelotti S: ABO genotyping by minisequencing analysis. Transfusion 44(6), 943-944 (2004).
20. Ogasawara K, Yabe R, Uchikawa M et al.: Molecular genetic analysis of variant phenotypes of the ABO blood group system. Blood 88(7), 2732-2737 (1996).
21. Guan JZ, Maeda T, Sugano M, Oyama J, Higuchi Y, Makino N: Change in the telomere length distribution with age in the Japanese population. Mol. Cell Biochem. 304(1-2), 353-360 (2007).
22. Sanchez JJ, Phillips C, Borsting C et al.: A multiplex assay with 52 single nucleotide polymorphisms for human identifcation. Electrophoresis 27(9), 1713-1724 (2006).
23. Eiberg H, Troelsen J, Nielsen M et al.: Blue eye color in humans may be caused by a perfectly associated founder mutation in a regulatory element located within the HERC2 gene inhibiting OCA2 expression. Hum. Genet. 123(2), 177-187 (2008).
24. Kayser M, Liu F, Janssens AC et al.: Three genome-wide association studies and a linkage analysis identify HERC2 as a human iris color gene. Am. J. Hum. Genet. 82(2), 411-423 (2008).
25. Sturm RA, Duffy DL, Zhao ZZ et al.: A single SNP in an evolutionary conserved region within intron 86 of the HERC2 gene determines human blue-brown eye color. Am. J. Hum. Genet. 82(2), 424-431 (2008).
26. Sulem P, Gudbjartsson DF, Stacey SN et al.: Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat. Genet. 39(12), 1443-1452 (2007).
27. Jobling MA, Gill P: Encoded evidence: DNA in forensic analysis. Nat. Rev. Genet. 5(10), 739-751 (2004).
28. Mannucci A, Sullivan KM, Ivanov PL, Gill P: Forensic application of a rapid and quantitative DNA sex test by amplifcation of the x-y homologous gene amelogenin. Int. J. Legal Med. 106(4), 190-193 (1994).
29. Steinlechner M, Berger B, Niederstatter H, Parson W: Rare failures in the amelogenin sex test. Int. J. Legal Med. 116(2), 117-120 (2002).
30. de la Chapelle A: The etiology of maleness in XX men. Hum. Genet. 58(1), 105-116 (1981).
31. Danilovic DL, Correa PH, Costa EM, Melo KF, Mendonca BB, Arnhold IJ: Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene. Osteoporos. Int. 18(3), 369-374 (2007).
32. Boehmer AL, Brinkmann AO, Sandkuijl LA et al.: 17b-hydroxysteroid dehydrogenase-3 defciency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J. Clin. Endocrinol. Metab. 84(12), 4713-4721 (1999).
33. Meineke I: An add-in implementation of the resampling syntax under Microsoft Excel. Comput. Methods Programs Biomed. 63(2), 99-104 (2000).